The Effect of Gene Editing by CRISPR-Cas9 of MiR-21 and the Indirect Target MMP9 in Metastatic Prostate Cancer
Overview
Chemistry
Molecular Biology
Authors
Affiliations
Prostate cancer (PCa) has a high prevalence and represents an important health problem, with an increased risk of metastasis. With the advance of CRISPR-Cas9 genome editing, new possibilities have been created for investigating PCa. The technique is effective in knockout oncogenes, reducing tumor resistance. MMP9 and miR-21 target genes are associated with PCa progression; therefore, we evaluated the MMP-9 and miR-21 targets in PCa using the CRISPR-Cas9 system. Single guide RNAs (sgRNAs) of MMP9 and miR-21 sequences were inserted into a PX-330 plasmid, and transfected in DU145 and PC-3 PCa cell lines. MMP9 and RECK expression was assessed by qPCR, WB, and IF. The miR-21 targets, integrins, BAX and mTOR, were evaluated by qPCR. Flow cytometry was performed with Annexin5, 7-AAD and Ki67 markers. Invasion assays were performed with Matrigel. The miR-21 CRISPR-Cas9-edited cells upregulated RECK, MARCKS, BTG2, and PDCD4. CDH1, ITGB3 and ITGB1 were increased in MMP9 and miR-21 CRISPR-Cas9-edited cells. Increased BAX and decreased mTOR were observed in MMP9 and miR-21 CRISPR-Cas9-edited cells. Reduced cell proliferation, increased apoptosis and low invasion in MMP9 and miR-21 edited cells was observed, compared to Scramble. CRISPR-Cas9-edited cells of miR-21 and MMP9 attenuate cell proliferation, invasion and stimulate apoptosis, impeding PCa evolution.
Zhang S, Li M, Zeng J, Zhou S, Yue F, Chen Z J Nanobiotechnology. 2025; 23(1):127.
PMID: 39979929 PMC: 11844079. DOI: 10.1186/s12951-025-03214-3.
CRISPR/Cas9 Technology Providing the Therapeutic Landscape of Metastatic Prostate Cancer.
Park J, Kim J Pharmaceuticals (Basel). 2025; 17(12.
PMID: 39770431 PMC: 11676443. DOI: 10.3390/ph17121589.
MiR-21 Regulates Growth and Migration of Cervical Cancer Cells by RECK Signaling Pathway.
Aguilar-Martinez S, Campos-Viguri G, Medina-Garcia S, Garcia-Flores R, Deas J, Gomez-Ceron C Int J Mol Sci. 2024; 25(7).
PMID: 38612895 PMC: 11012906. DOI: 10.3390/ijms25074086.